Volume | 40,328 |
|
|||||
News | - | ||||||
Day High | 2.7399 | Low High |
|||||
Day Low | 2.61 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Vivos Therapeutics Inc | VVOS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.69 | 2.61 | 2.7399 | 2.72 | 2.66 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
289 | 40,328 | $ 2.66 | $ 107,117 | - | 2.40 - 48.79 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:58:58 | 11 | $ 2.65 | USD |
Vivos Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.26M | 1.20M | - | 13.8M | -13.58M | -11.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Vivos Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VVOS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.79 | 2.90 | 2.45 | 2.71 | 98,367 | -0.11 | -3.94% |
1 Month | 4.89 | 5.24 | 2.40 | 2.92 | 411,529 | -2.21 | -45.19% |
3 Months | 5.72 | 9.1391 | 2.40 | 4.09 | 225,407 | -3.04 | -53.15% |
6 Months | 7.25 | 48.79 | 2.40 | 27.98 | 656,914 | -4.57 | -63.03% |
1 Year | 9.45 | 48.79 | 2.40 | 11.50 | 1,902,529 | -6.77 | -71.64% |
3 Years | 209.00 | 215.00 | 2.40 | 50.95 | 1,374,573 | -206.32 | -98.72% |
5 Years | 176.75 | 360.25 | 2.40 | 56.76 | 1,278,194 | -174.07 | -98.48% |
Vivos Therapeutics Description
Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists. |